Additional Resources

Section

NORD rare disease drug development ad.

Get Information about a Rare Disease

Use the form below to explore NORD's comprehensive rare disease database. Search for detailed information on rare diseases, including NORD's authoritative Rare Disease Reports and data from other reliable sources.
* = NORD Rare Disease Report

Interested in exploring the database in detail?
Click here to explore the database in alphabetical order.

NORD Summit 2026 Banner Ad

acute myeloblastic leukemia with maturation

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

Connect & Download

Disease Overview

An acute myeloid leukemia (AML) characterized by blasts with evidence of maturation to more mature neutrophils. (WHO, 2001)

Synonyms

  • AM
  • AML M2
  • AML with maturation
  • FAB M2
  • LAM M2
  • M2 acute granulocytic leukaemia
  • M2 acute granulocytic leukemia
  • M2 acute myeloblastic leukaemia
  • M2 acute myeloblastic leukaemia with maturation
  • M2 acute myeloblastic leukemia
  • M2 acute myeloblastic leukemia with maturation
  • M2 acute myelocytic leukaemia with maturation
  • M2 acute myelocytic leukemia with maturation
  • M2 acute myelogenous leukaemia
  • M2 acute myelogenous leukaemia with maturation
  • M2 acute myelogenous leukemia
  • M2 acute myelogenous leukemia with maturation
  • M2 acute myeloid leukaemia
  • M2 acute myeloid leukaemia with maturation
  • M2 acute myeloid leukemia
  • M2 acute myeloid leukemia with maturation
  • acute M2 myeloid leukaemia
  • acute M2 myeloid leukemia
  • acute myeloblastic leukaemia M2
  • acute myeloblastic leukaemia type 2
  • acute myeloblastic leukemia M2
  • acute myeloblastic leukemia type 2
  • acute myelocytic leukaemia with maturation
  • acute myelocytic leukemia with maturation
  • acute myelogenous leukaemia with maturation
  • acute myelogenous leukemia with maturation
  • acute myeloid leukaemia (AML-M2)
  • acute myeloid leukaemia with maturation
  • acute myeloid leukemia (AML-M2)
  • acute myeloid leukemia with maturation
GARD Disease Summary

The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

View report
Orphanet

Orphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.

View report
Sign Up for NORD News

Access State Report Card Data

Please complete this form to access the requested resource.

Please consider sharing some basic information with us.

Name(Required)
Consent(Required)
This field is hidden when viewing the form